Hits: 5
First Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services - Appendix C
… infection in adults who are at low risk for infection. D Hormone Replacement Therapy: Preventive Medication for Postmenopausal Women The USPSTF recommends against the …
Public Comment on Draft Recommendation Statement and Draft Evidence Review: Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions
… statement and draft evidence review on menopausal hormone therapy for the primary prevention of chronic conditions. … and progestin for the prevention of chronic conditions in postmenopausal women. This is a D recommendation. The Task …
Final Recommendation Statement: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women
… Force released today a final recommendation statement on hormone therapy for the primary prevention of chronic conditions in postmenopausal women. The Task Force recommends against …
Public Comment on Draft Research Plan: Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women
… Force posted today a draft research plan on Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women. The draft research plan is available …
Shared Decision Making About Screening and Chemoprevention
… with recent evidence demonstrating the adverse effects of hormone replacement therapy (HRT) on the heart, 6 clinicians should consider … net benefit is small (e.g., osteoporosis screening in postmenopausal women under the age of 60 or aged 60-64 with …